[10] However, nearly 20% of individuals in whom a diagnosis of OTCD is made based on reduced enzyme activity do not have an identifiable pathogenic variant in the exons or exon–intron boundaries of OTC gene [10]. The gene discussed is OTC; the disease is ornithine carbamoyltransferase deficiency.